These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30071348)

  • 1. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
    Pellegrini S; Piemonti L; Sordi V
    Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological applications of stem cells in type 1 diabetes.
    Fiorina P; Voltarelli J; Zavazava N
    Endocr Rev; 2011 Dec; 32(6):725-54. PubMed ID: 21862682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
    Shen J; Cheng Y; Han Q; Mu Y; Han W
    Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
    Quiskamp N; Bruin JE; Kieffer TJ
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of induced pluripotent stem cells.
    Okita K; Nagata N; Yamanaka S
    Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell differentiation: therapeutical challenges in diabetes.
    Roche E; Vicente-Salar N; Arribas M; Paredes B
    J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Human Endocrine Pancreas: New Insights on Replacement and Regeneration.
    Domínguez-Bendala J; Lanzoni G; Klein D; Álvarez-Cubela S; Pastori RL
    Trends Endocrinol Metab; 2016 Mar; 27(3):153-162. PubMed ID: 26774512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
    Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
    Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of insulin-producing cells from primitive biologic precursors.
    Evans-Molina C; Vestermark GL; Mirmira RG
    Curr Opin Organ Transplant; 2009 Feb; 14(1):56-63. PubMed ID: 19337148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic stem cells: differentiation options.
    Rao MS; Reddy JK
    Stem Cell Rev; 2005; 1(3):265-71. PubMed ID: 17142864
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
    Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
    J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
    Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological Issues After Stem Cell-Based β Cell Replacement.
    Sordi V; Pellegrini S; Piemonti L
    Curr Diab Rep; 2017 Sep; 17(9):68. PubMed ID: 28726153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.
    Bartlett ST; Markmann JF; Johnson P; Korsgren O; Hering BJ; Scharp D; Kay TW; Bromberg J; Odorico JS; Weir GC; Bridges N; Kandaswamy R; Stock P; Friend P; Gotoh M; Cooper DK; Park CG; OʼConnell P; Stabler C; Matsumoto S; Ludwig B; Choudhary P; Kovatchev B; Rickels MR; Sykes M; Wood K; Kraemer K; Hwa A; Stanley E; Ricordi C; Zimmerman M; Greenstein J; Montanya E; Otonkoski T
    Transplantation; 2016 Feb; 100 Suppl 2(Suppl 2):S1-44. PubMed ID: 26840096
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cells to restore insulin production and cure diabetes.
    Sordi V; Pellegrini S; Krampera M; Marchetti P; Pessina A; Ciardelli G; Fadini G; Pintus C; Pantè G; Piemonti L
    Nutr Metab Cardiovasc Dis; 2017 Jul; 27(7):583-600. PubMed ID: 28545927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From stem cells to functional beta cells in type 1 diabetes].
    Engberg N; Hansson M; Madsen OD
    Ugeskr Laeger; 2010 Sep; 172(38):2608-12. PubMed ID: 20920405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts.
    Motté E; Szepessy E; Suenens K; Stangé G; Bomans M; Jacobs-Tulleneers-Thevissen D; Ling Z; Kroon E; Pipeleers D;
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E838-46. PubMed ID: 25205822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell-Based Therapies: A New Ray of Hope for Diabetic Patients.
    Khan J; Alexander A; Agrawal M; Ajazuddin ; Dubey SK; Siddique S; Saraf S; Saraf S
    Curr Stem Cell Res Ther; 2019; 14(2):146-151. PubMed ID: 30280677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.